AstraZeneca PLC (OTCMKTS:AZNCF) Sees Significant Drop in Short Interest

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 197,200 shares, a decline of 38.5% from the March 15th total of 320,500 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio is currently 89.6 days.

AstraZeneca Price Performance

AZNCF stock opened at $139.80 on Friday. The stock’s 50 day simple moving average is $145.44 and its 200 day simple moving average is $140.66. AstraZeneca has a 12-month low of $120.64 and a 12-month high of $175.00.

AstraZeneca Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, March 24th. Shareholders of record on Friday, February 21st were issued a dividend of $2.10 per share. This is a boost from AstraZeneca’s previous dividend of $1.00. The ex-dividend date of this dividend was Wednesday, February 19th. AstraZeneca’s dividend payout ratio is 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.